Alphatec Holdings Inc. (ATEC)’s Financial Results Comparing With InfuSystem Holdings Inc. (NYSEAMERICAN:INFU)

As Medical Instruments & Supplies companies, Alphatec Holdings Inc. (NASDAQ:ATEC) and InfuSystem Holdings Inc. (NYSEAMERICAN:INFU) are our subject to compare. And more specifically their profitability, analyst recommendations, risk, dividends, earnings and valuation, institutional ownership.

Valuation & Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Alphatec Holdings Inc. 6 -0.47 33.77M -1.27 0.00
InfuSystem Holdings Inc. 5 0.00 11.57M -0.11 0.00

Table 1 showcases the top-line revenue, earnings per share and valuation of Alphatec Holdings Inc. and InfuSystem Holdings Inc.


Table 2 hightlights the net margins, return on equity and return on assets of the two companies.

Net Margins Return on Equity Return on Assets
Alphatec Holdings Inc. 614,413,332.61% -209% -32.7%
InfuSystem Holdings Inc. 225,976,562.50% -10% -3.5%


The Current Ratio of Alphatec Holdings Inc. is 2.3 while its Quick Ratio stands at 1.2. The Current Ratio of rival InfuSystem Holdings Inc. is 0.9 and its Quick Ratio is has 0.7. Alphatec Holdings Inc. is better equipped to clear short and long-term obligations than InfuSystem Holdings Inc.

Analyst Ratings

Alphatec Holdings Inc. and InfuSystem Holdings Inc. Recommendations and Ratings are available on the next table.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Alphatec Holdings Inc. 0 0 3 3.00
InfuSystem Holdings Inc. 0 0 0 0.00

The upside potential is 37.10% for Alphatec Holdings Inc. with average target price of $6.67.

Institutional and Insider Ownership

Institutional investors owned 23.7% of Alphatec Holdings Inc. shares and 54.8% of InfuSystem Holdings Inc. shares. Alphatec Holdings Inc.’s share owned by insiders are 18.6%. Comparatively, 1.1% are InfuSystem Holdings Inc.’s share owned by insiders.


In this table we provide the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Alphatec Holdings Inc. 2.17% 0.97% 19.29% 207.19% 74.72% 105.24%
InfuSystem Holdings Inc. -1.34% -3.48% 2.78% 17.46% 40.96% 29.07%

For the past year Alphatec Holdings Inc.’s stock price has bigger growth than InfuSystem Holdings Inc.


Alphatec Holdings Inc. beats InfuSystem Holdings Inc. on 7 of the 11 factors.

Alphatec Holdings, Inc., a medical technology company, focuses on the design, development, manufacture, and marketing of products for the surgical treatment of spine disorders. Its product and procedural portfolio, as well as pipeline address the cervical, thoracolumbar, and intervertebral regions of the spine; and cover various spinal disorders and surgical procedures. The company offers MIS products consisting of Battalion Lateral Spacer System and Squadron Lateral Retractor, XYcor Expandable Spinal Spacer System, Illico Minimally Invasive Surgery System, and BridgePoint Spinous Process Fixation System; and thoracolumbar fixation products, such as Arsenal Degenerative, Arsenal Deformity, Arsenal CBx Cortical Bone Fixation, and Zodiac Degenerative Spinal Fixation systems. It also provides cervical and cervico-thoracic products, including Trestle Luxe Anterior Cervical Plate System, as well as Solanas Posterior Cervico/Thoracic Fixation System and Avalon Occipital Plate; and interbody systems, such as Battalion Universal Spacer System, Novel PEEK and Titanium Spinal Spacers, and Alphatec Solus Locking ALIF Spinal Spacer. In addition, the company offers biologics consisting of AlphaGraft Structural Allograft Spacers, AlphaGraft ProFuse Demineralized Bone Scaffold, Amnioshield Amniotic Tissue Barrier, Alphagraft Demineralized Bone Matrix, and Neocore Osteoconductive Matrix. It sells its products through a network of independent distributors and direct sales representatives in the United States. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.

InfuSystem Holdings Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology clinics, infusion clinics, hospital outpatient, and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole mounted and ambulatory infusion pumps; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. InfuSystem Holdings Inc. was founded in 2005 and is headquartered in Madison Heights, Michigan.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.